Clearside Biomedical, Inc. (CLSD) Financials

CLSD Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 34.0 million 49.9 million
2023-09-30 34.4 million 47.3 million
2023-06-30 39.2 million 44.2 million
2023-03-31 44.7 million 42.0 million

CLSD Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 375000 1.0 million
2023-09-30 -6.5 million 1.1 million
2023-06-30 -6.4 million 1.1 million
2023-03-31 -7.3 million 1.0 million

CLSD Net Income

No data available :(

CLSD Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 28.9 million - 1.0 million
2023-09-30 28.8 million - 1.1 million
2023-06-30 35.0 million - 1.2 million
2023-03-31 41.4 million - 1.2 million

CLSD Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 62.4 million
2023-09-30 62.0 million
2023-06-30 61.7 million
2023-03-31 61.2 million

CLSD Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 120000 6.3 million 2.9 million -
2023-09-30 445000 5.1 million 2.6 million -
2023-06-30 1.1 million 4.9 million 3.1 million -
2023-03-31 115000 4.5 million 3.2 million -

CLSD Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 6.3 million 20000
2023-09-30 859000 142000
2023-06-30 1.0 million 213000
2023-03-31 4000 15000

CLSD

Price: $1.31

52 week price:
0.65
2.12

Earnings Per Share: -0.53 USD

P/E Ratio: -2.24

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 411200

Ebitda: -18.1 million

Market Capitalization: 97.9 million

Links: